Skip to content

Pelvic Floor Symptoms Across Menopausel Stages

Comparison of Lower Urinary Tract Symptoms, Bowel Function, and Sexual Health Across Menopausal Stages in Women

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07690137
Enrollment
180
Registered
2026-07-08
Start date
2026-07-06
Completion date
2026-10-06
Last updated
2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause, Perimenopausal Disorder

Keywords

Menopausal transition, Lower urinary tract symptoms, Bowel functions, Sexual functions

Brief summary

The menopausal transition is associated with substantial hormonal alterations that may adversely affect lower urinary tract function, bowel function, and sexual health. Although these symptoms are common, few studies have comprehensively evaluated all three pelvic floor compartments across different menopausal stages. The aim of this study is to compare lower urinary tract symptoms, bowel symptoms, and female sexual function among women in the perimenopausal, early postmenopausal, and late postmenopausal stages. In addition, the relationship between menopausal stage and symptom severity will be investigated.

Detailed description

Menopause is characterized by estrogen deficiency, resulting in structural and functional alterations in pelvic floor tissues. Lower urinary tract symptoms, bowel dysfunction, and female sexual dysfunction are increasingly recognized as important health concerns during the menopausal transition. Despite growing evidence regarding individual pelvic floor disorders, few studies have simultaneously evaluated urinary, colorectal, and sexual symptoms across different menopausal stages. This study will classify women according to STRAW+10 criteria into: Perimenopause Early postmenopause Late postmenopause Participants will undergo a single assessment session. Demographic information together with validated questionnaires will be collected. No intervention or treatment will be provided.

Interventions

OTHERAssessment for Lower Urinary Tract Symptoms

Lower urinary tract symptoms will be assessed using the validated Bristol Female Lower Urinary Tract Symptoms questionnaire. Higher scores indicate greater symptom severity and poorer urinary health-related quality of life.

OTHERAssessment for Bowel Symptoms

Bowel symptoms and colorectal-anal distress will be evaluated using the Colorectal Anal Distress Inventory-8. Higher scores indicate greater symptom severity and distress related to bowel dysfunction.

OTHERConstipation Severity Assessment

Constipation severity will be assessed using the Cleveland Clinic Constipation Score. Higher scores represent more severe constipation symptoms.

Female sexual function will be assessed using the Female Sexual Function Index, a validated questionnaire evaluating desire, arousal, lubrication, orgasm, satisfaction, and pain. Higher scores indicate better sexual function.

Sponsors

Bezmialem Vakif University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Female * Age 40-65 years * Intact uterus and at least one ovary * Perimenopause or postmenopause according to STRAW+10 criteria * Able to read and understand Turkish

Exclusion criteria

* Hormone replacement therapy within the previous 6 months * Oral contraceptive use * Antipsychotic medication use * Previous pelvic surgery * Neurological or systemic diseases affecting bladder or bowel function * Active urinary tract or vaginal infection * Pelvic radiotherapy or chemotherapy history * Active gynecological or urological malignancy * Alcohol or substance abuse during the previous year

Design outcomes

Primary

MeasureTime frameDescription
Bristol Female Lower Urinary Tract Symptoms (BFLUTS) ScoreBaseline (single assessment)Lower urinary tract symptoms will be assessed using the validated Bristol Female Lower Urinary Tract Symptoms questionnaire. Higher scores indicate greater symptom severity and poorer urinary health-related quality of life

Secondary

MeasureTime frameDescription
Colorectal Anal Distress Inventory-8 (CRADI-8)Baseline (single assessment)Bowel symptoms and colorectal-anal distress will be evaluated using the Colorectal Anal Distress Inventory-8. Higher scores indicate greater symptom severity and distress related to bowel dysfunction.
Cleveland Clinic Constipation ScoreBaseline (single assessment)Constipation severity will be assessed using the Cleveland Clinic Constipation Score. Higher scores represent more severe constipation symptoms.
Bristol Stool Form ScaleBaseline (single assessment)The Bristol Stool Form Scale is a 7-category scale ranging from Type 1 (hard stools) to Type 7 (watery stools). Values range from 1 to 7. Lower scores indicate harder stool consistency, whereas higher scores indicate looser stool consistency.
Female Sexual Function IndexBaseline (single assessment)Female sexual function will be assessed using the Female Sexual Function Index, a validated questionnaire evaluating desire, arousal, lubrication, orgasm, satisfaction, and pain. Higher scores indicate better sexual function.

Countries

Turkey (Türkiye)

Contacts

CONTACTBetul CINAR, PhD
betulbirik@gmail.com+905327879969
CONTACTBetul Cinar, PhD
bcinar@bezmialem.edu.tr+90 212 523 22 88
STUDY_CHAIRBetul Cinar, PhD

Bezmialem Vakif University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026